Supernus Pharmaceuticals reported $44.02M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Abbott USD 6.95B 315M Jun/2025
ANI Pharmaceuticals USD 138.32M 907K Jun/2025
Aurora Cannabis CAD 228.26M 25.75M Jun/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Canopy Growth CAD 93.82M 3.07M Jun/2025
Corcept Therapeutics USD 12.28M 3.26M Jun/2025
Eisai JPY 227.32B 11.41B Jun/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Novo Nordisk 45.65B 21.26B Jun/2025
Pacira USD 148.16M 14.41M Jun/2025
Perrigo USD 1.22B 60.5M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
Supernus Pharmaceuticals USD 44.02M 5.4M Jun/2025
United Therapeutics USD 169.2M 3.8M Jun/2025
Xeris Pharmaceuticals USD 67.28M 14.59M Jun/2025